Date: 2015-10-29
Type of information: Opening of new premises
Compound:
Company: Domainex (UK)
Therapeutic area: Technology - Services
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: * On October 29, 2015, Domainex announced that it is expanding all aspects of its drug discovery service business including biology, analytical chemistry and medicinal chemistry. In order to provide the infrastructure required to support this expansion Domainex has signed a long-term lease with Aviva Investors for a laboratory building at Chesterford Research Park, Cambridge. Domainex and Aviva Investors are planning to invest several million pounds in the new research building.
Financial terms:
Latest news:
